Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,243 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

for
Metastatic HER2-Negative Breast Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05770531

Phase 2, Recruiting

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

for
Aortic Valve Insufficiency, Aortic Valve Stenosis
Location: Nashville TN, Atlanta GA, Cincinnati OH, Charlotte NC,
Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT05172973

Recruiting

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Nashville TN, Jacksonville FL, Green Bay WI, Weston FL,
Sponsor: Academic and Community Cancer Research United

Sex: All

Age: 18+

Code: NCT04660760

Phase 2, Recruiting

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

for
Head and Neck Cancer, Locally Advanced Head and Neck Carcinoma
Location: Nashville TN
Sponsor: Natalie Lockney

Sex: All

Age: 21+

Code: NCT05156060

Phase 1, Phase 2, Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

for
Pulmonary Invasive Fungal Infections,
Location: Nashville TN, Memphis TN, Atlanta GA, Cincinnati OH,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 21

Code: NCT03827694

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Nashville TN, Cleveland OH, Dallas TX, Duarte CA,
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05361720

Phase 2, Recruiting

Genetics of Appendix Cancer Study

for
Appendix Cancer, Appendiceal Cancer, Appendiceal Neoplasms,
Location: Nashville TN
Sponsor: Andreana Holowatyj, PhD, MSCI

Sex: All

Age: 18+

Code: NCT05734430

Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Nashville TN, Huntsville AL, Evansville IN,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Nashville TN, Carterville IL, Cape Girardeau MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase 2, Recruiting

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Eben Rosenthal

Sex: All

Age: 19+

Code: NCT05747625

Phase 1, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Nashville TN, Chattanooga TN, Louisville KY,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing

for
Lung Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06105801

Recruiting

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

for
Relapsed Myelodysplastic Syndrome,
Location: Nashville TN, Memphis TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06399640

Phase 1, Recruiting

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

for
Metastatic Oropharyngeal Carcinoma,
Location: Nashville TN, Birmingham AL
Sponsor: Michael K. Gibson

Sex: All

Age: 18+

Code: NCT05799144

Phase 2, Recruiting

INHANCE Stemless Reverse Shoulder IDE

for
Arthroplasty, Replacement, Shoulder
Location: Columbia TN, Cincinnati OH, Charlotte NC, Columbia MO,
Sponsor: DePuy Orthopaedics

Sex: All

Age: 22+

Code: NCT06323980

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Nashville TN, Cape Girardeau MO, Lexington KY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase 2, Recruiting

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

for
Advanced Malignant Solid Neoplasm,
Location: Nashville TN, Lee's Summit MO, Overland Park KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05691491

Phase 1, Phase 2, Recruiting

Inherited CAncer REgistry

for
Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT03231891

Recruiting

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

for
Metastatic Colorectal Carcinoma,
Location: Nashville TN, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05803382

Phase 1, Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Franklin TN, Tullahoma TN, Chattanooga TN, Cullman AL,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase 3, Recruiting